Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Samelisant by Suven Life Sciences for Narcolepsy: Likelihood of Approval
Samelisant is under clinical development by Suven Life Sciences and currently in Phase II for Narcolepsy. According to GlobalData, Phase...